Aadi Bioscience

United States
Pacific Palisades, Hawaii, United States
(424) 744-8055 ★

Company profile

Aadi Bioscience company profile

Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Aadi’s initial focus is the treatment of an ultra-rare cancer PEComa, also known as perivascular epithelioid cell tumor.

Business identity

Contact email
[email protected]
Phone number
(424) 744-8055
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$10K+
Founded
2011-09-30

Headquarters

Headquarters
Pacific Palisades, Hawaii, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
4
Total equity funding
$350.5M
Last funding
Post Ipo Equity / $100M / 2025-03-04
Last equity funding
Post Ipo Equity / $100M
Investors
24
Lead investors
4
Founders
1
Articles
92
Exited on
2021-08-27

Founders and investors

Founders

Neil Desai

Lead investors

Acuta Capital PartnersAlly Bridge GroupHermed CapitalKVP Capital

Investors

Ally Bridge GroupInvusOrbiMedRTW InvestmentsVivo Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.